The experimental results showed that albumin nanoparticles modified by the technology of reverse QTY code can maintain its biological activities and target tumor tissue or cells efficiently via the GP60 receptor and SPARC pathway (Meng et al., 2023). Here, SPARC is linked to neoplasm.